Xencor (XNCR) Change in Taxes (2016 - 2024)
Xencor (XNCR) reported Change in Taxes of $1.4 million for Q4 2024, down 89.62% year-over-year from $13.6 million in Q1 2024, and down 89.62% quarter-over-quarter from $13.6 million in Q4 2023.
Xencor (XNCR) Change in Taxes (2016 - 2024) Analysis & Trends
Xencor (XNCR) has 8 years of Change in Taxes data on file, last reported at $1.4 million in Q4 2024.
- Change in Taxes for Q4 2024 came in at $1.4 million, down 89.62% year-over-year; the trailing twelve-month figure through Dec 2024 was $15.0 million (up 31.37% YoY), and the FY2025 annual result was $3.6 million, up 180.04% from the prior year.
- Change in Taxes fell to $1.4 million in Q4 2024 per XNCR's latest filing, from $13.6 million in the prior quarter.
- Over five years, Change in Taxes peaked at $13.6 million in Q4 2023 and troughed at -$1.8 million in Q4 2020.
- A 4-year average of $2.7 million and a median of $804000.0 in 2020 frame the typical range for Change in Taxes.
- The sharpest annual moves came in 2023 and 2024: Change in Taxes jumped 3613.66% in 2023, then tumbled 89.62% in 2024.
- A 4-year view of Change in Taxes shows it stood at -$1.8 million in 2020, then jumped by 78.32% to -$388000.0 in 2022, then jumped by 3613.66% to $13.6 million in 2023, then plunged by 89.62% to $1.4 million in 2024.
- Business Quant data shows XNCR's Change in Taxes at $1.4 million in Q4 2024, $13.6 million in Q4 2023, and -$388000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.42 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Dec 31, 2023 | 13.63 Mn |
| Dec 31, 2023 | 13.63 Mn |
| Dec 31, 2022 | -388,000.00 |
| Dec 31, 2022 | -388,000.00 |
| Dec 31, 2020 | -1.79 Mn |
| Dec 31, 2020 | -1.79 Mn |
| Sep 30, 2020 | 804,000.00 |
| Sep 30, 2020 | 804,000.00 |
| Dec 31, 2019 | -1.91 Mn |
| Dec 31, 2019 | -1.91 Mn |
| Sep 30, 2019 | -400,000.00 |
| Sep 30, 2019 | -400,000.00 |
| Jun 30, 2019 | 704,000.00 |
| Jun 30, 2019 | 704,000.00 |
| Mar 31, 2019 | 900,000.00 |
| Mar 31, 2019 | 900,000.00 |
| Dec 31, 2018 | -1,000.00 |
| Dec 31, 2018 | -1,000.00 |